Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
about
Hepatitis B virus infection: An insight into infection outcomes and recent treatment optionsHepatitis B virus reactivation with a rituximab-containing regimenHepatitis B virus reactivation with rituximab-containing regimenMouse models of hepatitis B virus infection comprising host-virus immunologic interactionsTherapeutic antiviral T cells noncytopathically clear persistently infected microglia after conversion into antigen-presenting cellsBinding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell FunctionsHepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzeesAnalysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing propertiesAnalysis of successful immune responses in persons infected with hepatitis C virusInduced immunity against hepatitis B virusPlasmodium cellular effector mechanisms and the hepatic microenvironmentDeterminants of viral clearance and persistence during acute hepatitis C virus infectionTiming of CD8 T cell effector responses in viral infectionsImmunology of hepatitis B virus and hepatitis C virus infectionSuppression of hepatitis B virus replication mediated by hepatitis A-induced cytokine production.Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection.The Role of cccDNA in HBV Maintenance.Activation-induced cell death in peripheral blood mononuclear cells (PBMCs) from patients with chronic hepatitis B may be related to abnormal production of interleukin 12 and 10.Protection of hepatocytes from cytotoxic T cell mediated killing by interferon-alpha.Prevention of hepatitis B virus reactivation under rituximab therapy.Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cellsHepatitis B Virus Immunopathology, Model Systems, and Current TherapiesImmune effectors required for hepatitis B virus clearanceHepatitis B Virus e Antigen Activates the Suppressor of Cytokine Signaling 2 to Repress Interferon Action.Understanding the Complex Patterns Observed during Hepatitis B Virus Therapy.MHC Class I Presented T Cell Epitopes as Potential Antigens for Therapeutic Vaccine against HBV Chronic InfectionToll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.Tumor necrosis factor (TNF)-alpha and TNF receptors in viral pathogenesis.Intrahepatic T cells in hepatitis B: viral control versus liver cell injury.Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids.Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population.Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance.A virological perspective on the need for vaccination.Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infectionParacrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesisModeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems.Molecular pathogenesis of viral hepatitis.Transforming growth factor-β1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4α expression.Bone marrow transplantation concurrently reconstitutes donor liver and immune system across host species barrier in mice
P2860
Q26782127-684729A3-F531-4413-A2CC-F5A4836BA341Q26785963-41B6434B-31BE-45F3-A53D-12D8FB9E0A01Q26830484-0098BF5E-B19B-4693-9938-0ECE3FD4A86CQ27002598-58D9AA9A-706B-4342-BE20-75CF8E2C826FQ27308832-D605A312-F133-4D51-A656-3DE5936B6B42Q27485145-F4692AB4-9694-4295-AB28-E6CFAFD27858Q27489101-42ADF204-E7ED-43B1-8708-0225A9EFF890Q27491282-5EE6A9DD-863C-464B-82C9-65427B8A268DQ27860698-6485EED8-98CB-43FE-B954-BF46BDC35BF6Q28080525-40882D16-3053-448B-8804-2212E2275DEEQ28081143-601CAE8D-551E-4558-81C8-78E223C0DE98Q28131757-956BCE0F-2F3E-4972-B4B6-73BCE9773A8CQ28602935-BBDC5BBF-3244-477B-9C36-1724AB2EEBC6Q29618957-8A4FF61A-0C18-470F-9942-6CDCCC84EF08Q31906856-45282641-83CF-4A1D-A544-57D8E31277EDQ32159849-A1C1CAE4-7D6A-4A76-AB62-0ECD0908FAA5Q32182914-DA66B80A-45C3-4BF2-9F6B-DA16E13758B9Q33181584-4AE623E6-9DA4-4E12-A08D-B36BA58A585EQ33295380-EBC43D55-E6EA-440D-89A9-62A7A2B89459Q33390799-8FEA2D01-B7AB-4745-ADB9-43FC6BB5C979Q33539769-93149E0F-0195-4377-8174-1C07C4DBAA45Q33559657-70A950E0-C390-4973-A36A-9294EB8C3C57Q33640225-2234D6A6-E708-4745-85CF-7CD7B1E1A32EQ33687074-5FD01B2E-6980-47D2-9955-5AAB3DFEE3AFQ33753991-DEE253B2-6D47-4929-8DD3-EB1E5BFC3588Q33757923-2F51C595-E5AB-406A-B876-E0FA9622E2B5Q33812840-BD6B65EB-AC90-4187-8B48-6E9015F8A5B5Q33864445-488994CB-9BB5-41B8-9B66-8E1F58376E61Q33894481-531FD280-5A0C-4F99-AAFD-62DD6781FE7FQ33896072-CA22861E-99D6-499E-8D07-A7A62CC3CAF4Q33905171-1D90B28E-7D45-4272-8AD6-1707D387CD8AQ33926143-A0DDFDBE-3607-4818-B231-55EA4668F509Q33933196-C099D42A-D8A3-4E79-95C2-2B4C44D3BB9CQ33950163-E95FB491-CABC-4AF5-ADA9-134AED29B88EQ34005464-76BB7C7F-20CC-4EBB-8CCD-C082F00279A3Q34068117-B6C3EAF0-9DBF-4C1A-A668-9AD29C078857Q34082747-06A45FC1-4108-42BF-A51A-6E6D44CA68EBQ34095695-F74D59F3-2DCA-42DC-A877-618D31A8BCDDQ34140521-4148D358-5976-485E-A4FC-4310F9DBD1F1Q34142453-2C8E8305-2AA8-44A0-BB4F-B343514C2B27
P2860
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
description
article publié dans la revue scientifique Science
@fr
im April 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in Science
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 1999
@uk
name
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
@en
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
@nl
type
label
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
@en
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
@nl
prefLabel
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
@en
Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection
@nl
P2093
P1433
P1476
Viral clearance without destruction of infected cells during acute HBV infection
@en
P2093
P304
P356
10.1126/SCIENCE.284.5415.825
P407
P577
1999-04-01T00:00:00Z